Homeopathic Drug Product Safety, Quality, and Transparency Act

This bill would create a separate legal category for homeopathic drug products under federal food and drug law. These products would not need FDA approval before sale, and only certain sections of the drug law would apply to them. The FDA would have to issue manufacturing and labeling rules within 3 years, and retail products would need a label saying their intended uses have not been evaluated by the FDA. The bill would also create a temporary advisory committee on homeopathic products, bar dietary supplements, cosmetics, and other drugs from using the term "homeopathic" on labels, and cancel a 2022 FDA guidance on these products.

Full text and official record on Congress.gov

Sponsors

• Tommy Tuberville Republican sponsor
• 1 cosponsors